Refocus Group, Inc. Stock

Refocus Group, Inc. is a medical device company. The Company is involved in researching and developing treatments for human vision disorders, particularly for the treatment of presbyopia. It is engaged in providing treatment for near vision correction. The Company’s product, VisAbility Micro Insert System, is a binocular presbyopic treatment that works outside the visual axis. VisAbility Micro Insert System is under clinical trials in the United States and aims to help patients reduce or eliminate their need for reading glasses.